Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Tuesday, March 5, 2013

After Successful ALS Phase I, Neuralstem Branches Out

Back in October, when I first encountered Neuralstem , the stock was trading below all its moving averages at about $0.90 a share.

http://seekingalpha.com/article/1246601-after-successful-als-phase-i-neuralstem-branches-out?source=feed

No comments:

Post a Comment

Popular Stem Cell Roundup Posts